预测急性严重性结肠炎后的结果:当代审查和未来研究领域
Sudheer Kumar Vuyyuru1, Olga Maria Nardone2, Vipul Jairath1,3,4
1Departments of Medicine, Division of Gastroenterology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.
Journal of clinical medicine
|August 10, 2024
概括
识别患有急性严重性结肠炎 (ASUC) 皮质类固醇失效风险的患者至关重要. 早期的救援疗法,如因弗利克西马布或环素,对于预防小肠切除术至关重要,尽管新的口服药需要更多的研究.
科学领域:
- 胃肠病学 胃肠病学
- 内部医学 内部医学
- 临床治疗学 临床治疗学
背景情况:
- 急性严重性结肠炎 (ASUC) 是一种需要住院治疗和密集治疗以预防结肠切除的严重疾病.
- 早期识别可能失败的皮质类固醇患者是有效管理的关键.
- 目前在ASUC中对皮质类固醇失效的预测工具缺乏普遍验证.
研究的目的:
- 强调在ASUC中及时识别皮质类固醇失效的重要性.
- 讨论ASUC选择医疗救援疗法的作用和影响因素.
- 审查目前和新兴的ASUC治疗选择.
主要方法:
- 关于ASUC管理和预测模型的现有文献的审查.
- 在ASUC中对医疗救援疗法的当前建议进行分析.
- 对既有 (因弗力西马布,环素) 和新型 (托法西提尼布,乌帕达西提尼布) 治疗方法的证据评估.
主要成果:
- 因弗利西马布和环素是ASUC的主要推的救援疗法.
- 在ASUC中,口服小分子 (如托法西提尼布和乌帕达西提尼布) 的有效性和安全性的证据有限.
- 多学科团队的参与和患者的偏好在治疗决策中很重要.
结论:
- 在ASUC中,迅速评估对医疗救援疗法的反应至关重要.
- 在治疗失败的情况下,应避免延迟手术干预.
- 需要进一步的研究来确定新型口服药在ASUC管理中的作用.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease V: Surgical Management
134
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
134
Drugs for Treatment of Ulcerative Colitis in IBD
133
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
133
Peptic Ulcer Disease IV: Management
79
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
79
Chronic Bowel Disorders: Introduction
436
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
436


